Remote Doctor

Editorial standards

Sourcing, conflicts, corrections, and the review cycle.

This page describes how Remote Doctor sources, fact-checks, updates, and corrects its content. It is intentionally specific so that readers can hold the site to its own standards.

Sourcing

Pages on this site rely on three categories of source material, in roughly this order of preference: primary regulatory and government sources; major professional medical society guidance; and peer-reviewed literature for clinical claims that are not adequately covered by the first two. Where a page makes a claim that is broadly accepted as common knowledge among clinicians, we treat it as such; where a claim is contested or evolving, we say so explicitly.

Primary regulatory sources

For US healthcare regulatory claims, we rely on the agencies themselves: the Department of Health and Human Services Office for Civil Rights (OCR) for HIPAA; the Office of the National Coordinator for Health IT (ONC) for the 21st Century Cures Act and information blocking; the Centers for Medicare and Medicaid Services (CMS) for Medicare and Medicaid coverage; the Drug Enforcement Administration (DEA) for controlled substance rules; the Food and Drug Administration (FDA) for drug approval and device clearance; the Federation of State Medical Boards (FSMB) and individual state medical boards for licensing and practice rules.

Professional society guidance

For clinical claims, we cite professional society positions where they are stable and well-known: the American Heart Association (AHA) and American College of Cardiology (ACC) for cardiovascular topics; the American Diabetes Association (ADA) for diabetes; the American Academy of Pediatrics (AAP) for pediatric care; the American Academy of Dermatology (AAD) for dermatology; the Menopause Society (NAMS) for menopause; the American Medical Association (AMA) for ethics and practice; and similar bodies for other specialties.

Peer-reviewed literature

For specific clinical claims not adequately addressed by the above, we look to peer-reviewed literature, with preference for systematic reviews and large clinical trials over single observational studies. We try to indicate when a claim rests on a single study versus established evidence.

What we do not source from

Specific telehealth services' marketing materials are not used as sources for clinical or regulatory claims. Wellness apps, influencer content, and sponsored health content are not used as sources. Press releases from drug manufacturers may be cited for specific events (an FDA approval, for example) but are not used as the basis for clinical claims.

Conflicts of interest

Remote Doctor does not accept payment for placement. There are no affiliate links, no sponsored reviews, no advertorial content, and no paid endorsements on the site. Editorial decisions are not influenced by any commercial relationship.

The editorial team does not hold equity in or receive consulting income from named telehealth services discussed on the site. If a future situation involved a potential conflict — for example, an editor having a relevant prior employment relationship with a service the site discusses — we would disclose it on the relevant page or recuse the editor from that topic. Where there is a conflict that cannot be cleanly avoided, we say so.

What we will write about

What we will not write

Update cadence

Pages addressing fast-moving regulatory matters — DEA controlled substance telehealth rules, Medicare telehealth coverage, GLP-1 compounding rules, FDA drug shortage status — are reviewed more frequently than pages addressing stable topics. When a regulatory or clinical fact on the site materially changes, we update the relevant pages and note the change in the page's dateModified field.

For static topics — how to take a blood pressure measurement, how to photograph a skin condition — pages are reviewed periodically and updated as needed.

The site is not a news outlet and does not chase short-term updates. Where the current state of a rule is in flux, we direct readers to primary sources for verification rather than asserting a state that may be wrong by the time the reader arrives at the page.

Corrections

If a page contains a factual error, we correct it. The correction is made directly to the page text and the dateModified field is updated. Substantive corrections — corrections that change the meaning of a claim, not typos or formatting — are noted at the bottom of the page when warranted.

To submit a correction, see contact. Useful corrections include: a regulatory citation we got wrong, a clinical claim that misstates current professional guidance, an outdated fact about an evolving rule, an internal link that does not work, or any other clear factual error. We may not change editorial judgments simply because a reader disagrees, but we engage with reasonable counter-arguments.

Medical content review

Clinical content is reviewed for accuracy by editors with healthcare or healthcare policy experience. We do not represent any specific page as having been written or signed off by a particular named clinician. The medical disclaimers on every page reflect the limits of editorial guidance: the site provides educational information, not personalized medical advice. Patients with specific medical questions should bring them to a licensed clinician who knows them.

Accuracy over completeness

When a regulatory claim varies by state or has changed recently, we say so explicitly and direct the reader to confirm with the relevant agency. When a clinical question has uncertainty in the underlying evidence, we say so rather than pretending the matter is settled. We prefer to omit a fact we are not confident in rather than guess.

Date stamps

Each article includes a published date and a last-modified date in its JSON-LD structured data. For regulatory claims that are changing, we sometimes include "as of [year]" language in the body so that readers know the claim was current as of writing rather than today. When in doubt about a current rule, the reader should verify with the relevant primary source.

Plain language

The editorial voice is plain English, calm, opinionated where opinion adds clarity, neutral where it does not. We avoid medical jargon when a plainer phrasing would be just as accurate. We avoid hyperbole, marketing-style language, and clickbait phrasings. We do not use exclamation marks except in direct quotes.

What gets named, what does not

We name agencies (CMS, FDA, DEA, OCR, ONC, FSMB, FTC). We name laws (HIPAA, the 21st Century Cures Act, the Ryan Haight Act, the No Surprises Act, the Mainstreaming Addiction Treatment Act). We name medications by their generic name and, where useful for clarity, brand names alongside (e.g., "semaglutide (Ozempic, Wegovy)"). We name validated device organizations (validatebp.org, dabl, STRIDE-BP) and ABMS verification (certificationmatters.org).

We do not name specific telehealth services as "best" or "worst." We may refer to category-level facts about how some platforms operate (for example, "some services operate as asynchronous-only platforms") without ranking or endorsing.

Reader feedback

Reader feedback shapes the site over time. Topics that are unclear are clarified; missing topics are added when they fit the editorial scope. Reader email about specific medical situations is acknowledged but not answered with medical guidance — see contact.

What this page commits to

Related reading

Not medical advice. This site provides general educational information about navigating remote healthcare. It does not diagnose, treat, or recommend treatment for any condition. For personal medical questions, talk to a licensed clinician.